Search

Your search keyword '"Sudo, Kazuki"' showing total 615 results
Start Over Author "Sudo, Kazuki"
615 results on '"Sudo, Kazuki"'

201. A phase I study of combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients who were previously treated with fluoropyrimidine, oxaliplatin, irinotecan, and bevacizumab.

Author

Takahashi, Naoki, primary, Iwasa, Satoru, additional, Tachikawa, Masanori, additional, Fukahori, Masaru, additional, Sudo, Kazuki, additional, Sasaki, Yusuke, additional, Shoji, Hirokazu, additional, Honma, Yoshitaka, additional, Okita, Natsuko, additional, Takashima, Atsuo, additional, Hamaguchi, Tetsuya, additional, Boku, Narikazu, additional, Shimada, Yasuhiro, additional, Yamagiwa, Koki, additional, Ebata, Yuka, additional, Uchida, Yasuo, additional, Honda, Kazufumi, additional, Terasaki, Tetsuya, additional, and Yamada, Yasuhide, additional

Published
2016
Full Text
View/download PDF

202. PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system.

Author

Shimoi, Tatsunori, Hamada, Akinobu, Yamagishi, Marifu, Hirai, Mitsuharu, Yoshida, Masayuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimomura, Akihiko, Noguchi, Emi, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Kinoshita, Takayuki, Fukuda, Takahiro, Fujiwara, Yasuhiro, and Tamura, Kenji

Abstract

PIK3CA mutations are common activating mutations associated with breast cancer (occurring in 20–30% of all cases) and are potent predictive markers for responses to PI3K inhibitors. Thus, it is important to develop sensitive methods to detect these mutations. We established a novel detection method using a quenching probe (QP) system to identify PIK3CA mutations, using DNA from 309 breast cancer tissues. In a developmental cohort, we determined the optimal detection threshold of the QP system with human tumor DNA from 119 freshly frozen tumor samples. We found a 96% concordance rate with the QP system between DNA from 26 matching fresh‐frozen specimens and formalin‐fixed paraffin‐embedded (FFPE) specimens from the same patients, and known PIK3CA mutation status in the developmental cohort. In a validation cohort, we evaluated whether the threshold for judging mutations using the QP system with frozen specimen‐derived DNA was applicable with FFPE‐derived DNA. In the validation cohort, 30 DNA samples from 190 FFPE‐derived DNA samples with known PIK3CA mutation status were analyzed by direct sequencing (DS) and droplet digital PCR, in a blinded manner. The sensitivity and specificity of the droplet digital PCR results were 100% and 100% (QP system), and 60% and 100% (DS), respectively. We also analyzed the relationship between clinical outcomes and the PIK3CA mutational status of 309 breast cancer samples, including the developmental cohort and validation cohort samples. Multivariate analysis suggested that PIK3CA mutations, especially H1047R, were prognostic factors of relapse‐free survival. Our novel detection system could be more useful than DS for detecting clinical PIK3CA mutations. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

203. Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study.

Author

Iizumi, Sakura, Shimomura, Akihiko, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, and Tamura, Kenji

Subjects
FLUOROPYRIMIDINES, BREAST cancer treatment, CANCER chemotherapy, DRUG efficacy, PROGRESSION-free survival, CANCER relapse, THERAPEUTICS
Abstract

Purpose: We conducted a retrospective study to assess the outcomes of capecitabine for advanced breast cancer (ABC) after perioperative fluoropyrimidines (FPs).Methods: The charts of patients with ABC who received capecitabine between 2008 and 2016 at the National Cancer Center Hospital (Tokyo, Japan) were reviewed. Progression-free survival (PFS), overall survival (OS), tumor response, and adverse events (AEs) were compared between two groups: an FP group (prior perioperative FP use) and a non-FP group (no prior FP use).Results: Overall, 288 patients (FP n = 105; non-FP n = 183) were analyzed. The two groups had similar patient characteristics. The FP group had significantly poorer PFS than the non-FP group (multivariate hazard ratio [HR] 1.33; 95% confidence interval [CI] 1.02-1.73; p = 0.036), although the OS did not differ significantly between the groups (multivariate HR 1.00; 95% CI 0.67-1.50; p = 0.994). With different cut-off values (relapse-free interval [RFI] = 3, 4, and 5 years), multivariate HRs for PFS were 1.32-1.67 (short RFI), and 1.00-1.25 (long RFI). A trend for a larger HR in the FP group compared to the non-FP group with short RFI than in that with long RFI was also seen for OS. Response rate (RR) and disease control rate (DCR) did not differ significantly between the groups (RR in FP vs non-FP 13.8 vs 21.0%; p = 0.173; DCR 54.0 vs 59.9%; p = 0.418). No significant difference in AEs existed between the groups.Conclusions: Extra caution is needed when capecitabine is considered for patients with ABC who used perioperative FP, especially those who had early recurrence. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

206. Patterns of local-regional relapse after complete response by definitive chemoradiotherapy for stage II/III (non–T4) esophageal squamous cell carcinoma.

Author

Sudo, Kazuki, primary, Kato, Ken, additional, Kuwabara, Hiroki, additional, Sasaki, Yusuke, additional, Takahashi, Naoki, additional, Shoji, Hirokazu, additional, Iwasa, Satoru, additional, Honma, Yoshitaka, additional, Okita, Natsuko T., additional, Takashima, Atsuo, additional, Hamaguchi, Tetsuya, additional, Yamada, Yasuhide, additional, and Boku, Narikazu, additional

Published
2015
Full Text
View/download PDF

207. Molecular Biomarkers in Gastric Cancer

Author

Elimova, Elena, primary, Wadhwa, Roopma, additional, Shiozaki, Hironori, additional, Sudo, Kazuki, additional, Estrella, Jeannelyn S., additional, Badgwell, Brian D., additional, Das, Prajnan, additional, Matamoros, Aurelio, additional, Song, Shumei, additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

208. Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma

Author

Shiozaki, Hironori, primary, Slack, Rebecca, additional, Sudo, Kazuki, additional, Elimova, Elena, additional, Wadhwa, Roopma, additional, Chen, Hsian-Chun, additional, Skinner, Heath D., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Rogers, Jane E., additional, Maru, Dipen M., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

209. Tu1964 - Serum Micrornas can Detect Colorectal Cancer; two Validation Study after In-Silico Analysis

Author

Takamaru, Hiroyuki, Saito, Yutaka, Sakamoto, Taku, Abe, Seiichiro, Yamada, Masayoshi, Nakajima, Takeshi, Matsuda, Takahisa, Hiroki, Ochiai, Kanemitsu, Yukihide, Sudo, Kazuki, Kato, Ken, Kawauchi, Junpei, Takizawa, Satoko, Sakamoto, Hiromi, Kojima, Motohiro, Ochiai, Atsushi, Niida, Shumpei, Ishii, Hideshi, Matsuzaki, Juntaro, and Ochiya, Takahiro

Published
2017
Full Text
View/download PDF

210. Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.

Author

Sudo, Kazuki, Kato, Ken, Kuwabara, Hiroki, Sasaki, Yusuke, Takahashi, Naoki, Shoji, Hirokazu, Iwasa, Satoru, Honma, Yoshitaka, Okita, Natsuko T., Takashima, Atsuo, Hamaguchi, Tetsuya, Yamada, Yasuhide, Ito, Yoshinori, Itami, Jun, Fukuda, Takahiro, Tobinai, Kensei, and Boku, Narikazu

Subjects
*ESOPHAGEAL tumors, *METASTASIS, *SQUAMOUS cell carcinoma, *TUMOR classification, *DISEASE relapse, *TREATMENT effectiveness, *DISEASE remission, *DATA analysis software, *DESCRIPTIVE statistics, *CHEMORADIOTHERAPY
Abstract

Purpose: The purpose of this study was to investigate the utility of surveillance after definitive chemoradiotherapy (dCRT) in patients with squamous cell carcinoma. Methods: Patients who underwent dCRT for stage II/III (excluding T4) esophageal squamous cell carcinoma were analyzed. First failures following complete response were classified into luminal relapse (LR), regional relapse (RR), distant metastasis (DM), new cancer diagnosed by esophagogastroduodenoscopy (NC-E), and new cancer other than NC-E (NC-O). We focused on LR, RR, and NC-E, and analyzed their frequency, timings and survival outcomes after local treatments. Results: Among 302 patients treated with dCRT, 204 achieved complete response. The number of patients who recurred with LR, RR, DM, NC-E, and NC-O were 28 (14% of 204), 13 (6%), 39 (19%), 34 (17%), and 16 (8%). Ninety-three percent of LRs were diagnosed within 3 years after dCRT, and all RRs were diagnosed within 2 years. Annual odds of NC-E did not decrease over time. Twenty-three patients with LR, 6 with RR, and 32 with NC-E underwent local treatment, and their median overall survivals were 49.2, 19.5, and 108.9 months. Conclusion: Surveillance with esophagogastroduodenoscopy may be important in the first 3 years after dCRT to detect LR and to detect NC-E beyond 3 years. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

211. Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2−) advanced breast cancer (ABC): Primary results of NCCH1607/PATHWAY, an Asian international double-blind randomized phase 3 trial

Author

Kogawa, Takahiro, Noguchi, Emi, Yamanaka, Takashi, Yamamoto, Naohito, Chung, Chi-Feng, Lu, Yen-Shen, Chang, Dwan-Ying, Sohn, Joohyuk, Kim, Gun Min, Lee, Kyung-Hun, Lee, Soo-Chin, Yap, Yoon Sim, Umeyama, Yoshiko, Sudo, Kazuki, Hata, Tomomi, Kuchiba, Aya, Shibata, Taro, Nakamura, Kenichi, Tamura, Kenji, and Yonemori, Kan

Published
2023
Full Text
View/download PDF

213. Actionable locoregional failures (LRFs) after therapy of localized esophageal carcinoma (LEC): Surveillance strategies and their benefits.

Author

Elimova, Elena, primary, Wang, Xuemei, additional, Qiao, Wei, additional, Sudo, Kazuki, additional, Wadhwa, Roopma, additional, Shiozaki, Hironori, additional, Planjery, Venkatram, additional, Charalampakis, Nikolaos, additional, Skinner, Heath Devin, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Komaki, Ritsuko, additional, Rice, David C., additional, Swisher, Stephen, additional, Blum, Mariela A., additional, Maru, Dipen M., additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

214. Prognosis of gastric cancer (GC) patients with positive peritoneal cytology.

Author

Shiozaki, Hironori, primary, Elimova, Elena, additional, Slack, Rebecca, additional, Chen, Hsiang-Chun, additional, Staerkel, Gregg A, additional, Sneige, Nour, additional, Planjery, Venkatram, additional, Charalampakis, Nikolaos, additional, Wadhwa, Roopma, additional, Sudo, Kazuki, additional, Matamoros, Aurelio, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Estrella, Jeannelyn, additional, Das, Prajnan, additional, Mansfield, Paul F., additional, Badgwell, Brian D., additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

215. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications

Author

Neishaboori, Nastaran, primary, Wadhwa, Roopma, additional, Nogueras-González, Graciela M., additional, Elimova, Elena, additional, Shiozaki, Hironori, additional, Sudo, Kazuki, additional, Charalampakis, Nikolaos, additional, Hiremath, Adarsh, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Blum, Mariela A., additional, Rogers, Jane E., additional, Garris, Jeana L., additional, Rice, David C., additional, Komaki, Ritsuko, additional, Swisher, Stephen G., additional, Skinner, Heath D., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

216. Early versus Delayed Therapy of Advanced Gastric Cancer Patients - Does It Make a Difference?

Author

Elimova, Elena, primary, Shiozaki, Hironori, additional, Slack, Rebecca S., additional, Chen, Hsiang-Chun, additional, Wadhwa, Roopma, additional, Sudo, Kazuki, additional, Charalampakis, Nikolaos, additional, Hiremath, Adarsh, additional, Estrella, Jeannelyn S., additional, Matamoros, Aurelio, additional, Sagebiel, Tara, additional, Das, Prajnan, additional, Rogers, Jane E., additional, Garris, Jeana L., additional, Blum, Mariela A., additional, Badgwell, Brian, additional, and Ajani, Jaffer A., additional

Published
2015
Full Text
View/download PDF

217. Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer

Author

Sudo, Kazuki, primary, Xiao, Lianchun, additional, Wadhwa, Roopma, additional, Shiozaki, Hironori, additional, Elimova, Elena, additional, Taketa, Takashi, additional, Blum, Mariela A., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Ross, William A., additional, Komaki, Ritsuko, additional, Rice, David C., additional, Swisher, Stephen G., additional, Hofstetter, Wayne L., additional, Maru, Dipen M., additional, Skinner, Heath D., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

218. Abstract 3896: The Hippo coactivator YAP1 upregulates SOX9 and endows cancer stem cell properties in non-transformed cells and esophageal cancer cells

Author

Song, Shumei, primary, Ajani, Jaffer A., additional, Honjo, Soichiro, additional, Maru, Dipen M., additional, Chen, Qiongrong, additional, Jin, Jiankang, additional, Scott, Ailing W., additional, Heallen, Todd R., additional, Xiao, Lianchun, additional, Hofstetter, Wayne L., additional, Weston, Brian, additional, Lee, Jeffrey H., additional, Wadhwa, Roopma, additional, Sudo, Kazuki, additional, Martin, James F., additional, Stroehlein, John R., additional, Hung, Mien-Chie, additional, and Johnson, Randy L., additional

Published
2014
Full Text
View/download PDF

219. Post-Chemoradiation Surgical Pathology Stage Can Customize the Surveillance Strategy in Patients With Esophageal Adenocarcinoma

Author

Taketa, Takashi, primary, Sudo, Kazuki, additional, Correa, Arlene M., additional, Wadhwa, Roopma, additional, Shiozaki, Hironori, additional, Elimova, Elena, additional, Campagna, Maria-Claudia, additional, Blum, Mariela A., additional, Skinner, Heath D., additional, Komaki, Ritsuko U., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian R., additional, Rice, David C., additional, Swisher, Stephen G., additional, Maru, Dipen M., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

220. Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties

Author

Song, Shumei, primary, Ajani, Jaffer A., additional, Honjo, Soichiro, additional, Maru, Dipen M., additional, Chen, Qiongrong, additional, Scott, Ailing W., additional, Heallen, Todd R., additional, Xiao, Lianchun, additional, Hofstetter, Wayne L., additional, Weston, Brian, additional, Lee, Jeffrey H., additional, Wadhwa, Roopma, additional, Sudo, Kazuki, additional, Stroehlein, John R., additional, Martin, James F., additional, Hung, Mien-Chie, additional, and Johnson, Randy L., additional

Published
2014
Full Text
View/download PDF

221. Reply to R. Gertler et al

Author

Sudo, Kazuki, primary, Elimova, Elena, additional, Skinner, Heath D., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

222. Outcomes of asymptomatic metastatic gastric cancer (MGC) patients when the initiation of systemic therapy is delayed.

Author

Wadhwa, Roopma, primary, Elimova, Elena, additional, Sudo, Kazuki, additional, Shiozaki, Hironori, additional, Slack, Rebecca, additional, Chen, Hsiang-Chun, additional, Badgwell, Brian D., additional, Matamoros, Aurelio, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Estrella, Jeannelyn, additional, Das, Prajnan, additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

224. A phase II study of preoperative chemotherapy and chemoradiation for localized gastric and gastroesophageal junction adenocarcinoma (LGCA).

Author

Elimova, Elena, primary, Wadhwa, Roopma, additional, Sudo, Kazuki, additional, Shiozaki, Hironori, additional, Slack, Rebecca, additional, Chen, Hsiang-Chun, additional, Badgwell, Brian D., additional, Matamoros, Aurelio, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Estrella, Jeannelyn, additional, Das, Prajnan, additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

225. Effect of the distribution of lymph node metastases on outcomes for trimodality-eligible patients with esophageal and esophagogastric junction adenocarcinoma (EAC).

Author

Shiozaki, Hironori, primary, Sudo, Kazuki, additional, Wadhwa, Roopma, additional, Elimova, Elena, additional, Slack, Rebecca, additional, Chen, Hsiang-Chun, additional, Skinner, Heath D., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Maru, Dipen M., additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

226. Distribution and timing of distant metastasis (DM) after definitive therapy for patients with esophageal and esophagogastric junction (E-EGJ) cancer.

Author

Shiozaki, Hironori, primary, Sudo, Kazuki, additional, Wadhwa, Roopma, additional, Hofstetter, Wayne Lewis, additional, Skinner, Heath D., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Maru, Dipen M., additional, Blum, Mariela A., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

227. Clinical parameters’ model for predicting distant metastasis (DM) following definitive therapy in patients with localized esophageal and esophagogastric junction (E-EGJ) cancer.

Author

Sudo, Kazuki, primary, Wang, Xuemei, additional, Wadhwa, Roopma, additional, Shiozaki, Hironori, additional, Hofstetter, Wayne Lewis, additional, Rice, David C., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Skinner, Heath D., additional, Komaki, Ritsuko, additional, Maru, Dipen M., additional, Blum, Mariela A., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

228. Correlation of pretreatment nuclear GLI-1 labeling indices (LIs) with initial SUV (iSUV) in esophageal cancer (EC) patients undergoing trimodality therapy (TMT): A potential pathway to esophageal preservation.

Author

Wadhwa, Roopma, primary, Wang, Xuemei, additional, Izzo, Julie, additional, Skinner, Heath D., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Ross, William A., additional, Hofstetter, Wayne Lewis, additional, Maru, Dipen M., additional, Rice, David C., additional, Sudo, Kazuki, additional, Shiozaki, Hironori, additional, Blum, Mariela A., additional, Chen, Qiongrong, additional, Jin, Jiankang, additional, Song, Shumei, additional, Baladandayuthapani, Veera, additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

230. Anal canal cancer: biology and therapy

Author

Elimova, Elena, primary, Wadhwa, Roopma, additional, Estrella, Jeannelyn S, additional, Sudo, Kazuki, additional, Shiozaki, Hironori, additional, Blum, Mariela A, additional, Chen, Qiongrong, additional, Song, Shumei, additional, Das, Prajnan, additional, and Ajani, Jaffer A, additional

Published
2014
Full Text
View/download PDF

231. Distribution and Timing of Distant Metastasis after Local Therapy in a Large Cohort of Patients with Esophageal and Esophagogastric Junction Cancer

Author

Shiozaki, Hironori, primary, Sudo, Kazuki, additional, Xiao, Lianchun, additional, Wadhwa, Roopma, additional, Elimova, Elena, additional, Hofstetter, Wayne L., additional, Skinner, Heath D., additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Blum, Mariela A., additional, Maru, Dipen M., additional, and Ajani, Jaffer A., additional

Published
2014
Full Text
View/download PDF

233. Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies

Author

Sudo, Kazuki, primary, Taketa, Takashi, additional, Correa, Arlene M., additional, Campagna, Maria-Claudia, additional, Wadhwa, Roopma, additional, Blum, Mariela A., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Skinner, Heath D., additional, Maru, Dipen M., additional, Rice, David C., additional, Swisher, Stephen G., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

235. Frequency of relapse over time based on baseline stage in esophageal cancer patients treated with definitive chemoradiation (DCRT).

Author

Wadhwa, Roopma, primary, Xiao, Lianchun, additional, Sudo, Kazuki, additional, Taketa, Takashi, additional, Blum, Mariela A., additional, Skinner, Heath D., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Komaki, Ritsuko, additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

236. Pattern of local-regional relapse and survival after bimodality therapy for esophageal cancer: Implications for the surveillance strategy.

Author

Sudo, Kazuki, primary, Xiao, Lianchun, additional, Wadhwa, Roopma, additional, Taketa, Takashi, additional, Blum, Mariela A., additional, Skinner, Heath D., additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Komaki, Ritsuko, additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

237. Various clinical outcomes in patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications.

Author

Suzuki, Akihiro, primary, Xiao, Lianchun, additional, Taketa, Takashi, additional, Sudo, Kazuki, additional, Blum, Mariela A., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Hofstetter, Wayne Lewis, additional, Swisher, Stephen, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

238. Customizing surveillance of patients with esophageal or esophagogastric junction adenocarcinoma (E-EGA) after trimodality therapy (TMT).

Author

Taketa, Takashi, primary, Correa, Arlene M., additional, Sudo, Kazuki, additional, Blum, Mariela A., additional, Wadhwa, Roopma, additional, Skinner, Heath D., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Liao, Zhongxing X., additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

239. 16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation.

Author

Taketa, Takashi, primary, Xiao, Lianchun, additional, Suzuki, Akihiro, additional, Blum, Mariela A., additional, Sudo, Kazuki, additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Lin, Steven H., additional, Wadhwa, Roopma, additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

241. Association of relapse in patients with esophageal and esophagogastric junction (E-EGJ) cancer with surgical stage after trimodality therapy (TMT): Implications for customized surveillance.

Author

Campagna, Maria-Claudia, primary, Taketa, Takashi, additional, Correa, Arlene M., additional, Sudo, Kazuki, additional, Blum, Mariela A., additional, Wadhwa, Roopma, additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Liao, Zhongxing X., additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

242. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer.

Author

Wadhwa, Roopma, primary, Taketa, Takashi, additional, Correa, Arlene M., additional, Sudo, Kazuki, additional, Blum, Mariela A., additional, Campagna, Maria-Claudia, additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Liao, Zhongxing X., additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

243. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy.

Author

Sudo, Kazuki, primary, Taketa, Takashi, additional, Correa, Arlene M., additional, Campagna, Maria-Claudia, additional, Wadhwa, Roopma, additional, Blum, Mariela A., additional, Komaki, Ritsuko, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Liao, Zhongxing X., additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne Lewis, additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

244. Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance

Author

Wadhwa, Roopma, primary, Taketa, Takashi, additional, Correa, Arlene M., additional, Sudo, Kazuki, additional, Campagna, Maria-Claudia, additional, Blum, Mariela A., additional, Komaki, Ritsuko, additional, Skinner, Heath, additional, Lee, Jeffrey H., additional, Bhutani, Manoop S., additional, Weston, Brian, additional, Maru, Dipen M., additional, Rice, David C., additional, Swisher, Stephen, additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

245. Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation

Author

Taketa, Takashi, primary, Xiao, Lianchun, additional, Sudo, Kazuki, additional, Suzuki, Akihiro, additional, Wadhwa, Roopma, additional, Blum, Mariela A., additional, Lee, Jeffrey H., additional, Weston, Brian, additional, Bhutani, Manoop S., additional, Skinner, Heath, additional, Komaki, Ritsuko, additional, Maru, Dipen M., additional, Rice, David C., additional, Swisher, Stephen G., additional, Hofstetter, Wayne L., additional, and Ajani, Jaffer A., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results